Form D · Biotechnology
InforMed Data Systems Inc.
New York, NY · CIK 0001644327
Offering snapshot reported Aug 24, 2020 · SEC filing
- Reported sold
- $34.7M Offering amount: $34.7M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 21, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 24, 2020 | Initial | $34,714,995 | No comparison | 7 | SEC filing |
| Sep 17, 2019 | Initial | $40,081,663 | No comparison | 26 | SEC filing |
| Dec 3, 2018 | Initial | $11,580,000 | No comparison | 9 | SEC filing |
| Apr 9, 2018 | Initial | $5,789,273 | No comparison | 12 | SEC filing |
| Jun 1, 2017 | Initial | $6,112,628 | No comparison | 20 | SEC filing |
| Jun 19, 2015 | Amendment | $8,592,028 | $329,998vs Jun 15, 2015 | 20 | SEC filing |
| Jun 15, 2015 | Initial | $8,262,030 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373908
Source: Form D, filed Aug 24, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Dachis | Director, Executive |
| Stuart Ellman | Director |
| Stefan Oelrich | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
166 Mercer Street 2 Nd Floor
New York, NY, 10012
New York, NY, 10012